POC Urinalysis Report - The Global Market (Analysis & Forecast, 2018-2022) is Dominated by Abbott, BD, Danaher, F. Hoffmann-La Roche, and Siemens Healthcare - ResearchAndMarkets.com

DUBLIN--()--The "Global POC Urinalysis Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

This market is projected to grow at a CAGR of over 3% by 2022.

With the increase in UTI's and nephropathic disorders, the demand for the diagnostic systems, especially POC has grown immensely over the last few years. The POC is the fastest growing segment of the diagnostic systems.

Several companies in this market develop and distribute products in partnership, which ultimately helps to cover a larger geographical area and obtain higher ROI as the product is co-developed and marketed. For instance, Sysmex, a diversified player, partnered with Siemens Healthcare to provide a fully integrated system called as CLINITEK AIPNi. Therefore, the growing partnerships within the industry will boost the growth of the POC urinalysis market.

Rising prevalence of nephropathic disorders and UTI's

Over the past few years, the lifestyle diseases like hypertension, diabetes, and obesity has significantly increased, adversely impacting excretion system which includes skin, urinary tract, bladder, and kidneys. As it impacts the content, appearance and concentration of urine, it leads to various nephropathic disorders. Whereas, UTI is the most common non-intestinal infection worldwide. These factors are poised to contribute to the growth of the POC urinalysis market.

Low efficacy of POC devices

There are several challenges with respect to POC, mainly related to quality assurance. To ensure the accuracy of the test result, the outcome of the result is often compared with the traditional pathology. Many rapid diagnostic kits have failed to provide accurate results, especially during emergencies. The uncertainty of result is hampering the adoption of POC diagnostic devices.

Competitive Landscape

With the presence of a considerable number of companies, this market appears to be fragmented. This market research report will help clients identify new growth opportunities. Many companies in the POC urinalysis market are focusing on selling their products in partnership that helps to cover a larger geographical area.

Market Trends

  • Emerging Technologies in POC
  • Growing Partnership
  • Growing Need of Companion Diagnostics

Key Players

  • Abbott
  • BD
  • Danaher
  • F. Hoffmann-La Roche
  • Siemens Healthcare

Topics Covered

1. Executive Summary

2. Scope of the Report

3. Research Methodology

4. Market Landscape

5. Market Sizing

6. Five Forces Analysis

7. Market Segmentation by Product

8. Customer Landscape

9. Regional Landscape

10. Decision Framework

11. Drivers and Challenges

12. Market Trends

13. Vendor Landscape

14. Vendor Analysis

For more information about this report visit https://www.researchandmarkets.com/research/w9xml2/poc_urinalysis?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, In Vitro Diagnostics, Point-of-Care Diagnostics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, In Vitro Diagnostics, Point-of-Care Diagnostics